Firefly Neuroscience AIFF
NASDAQ AIFF
$1.62 -0.07 (-4.14%)
At close: Sep 29, 2026 · 4:00 PM EDT

Firefly Neuroscience (AIFF) Non-Current Debt (2020 - 2021)

Updated

Firefly Neuroscience (AIFF) reported Non-Current Debt of $400,856 for Q3 2021, down 2.9% from $412,843 a year earlier and down 39.4% from the prior quarter.

Analysis

Firefly Neuroscience (AIFF) Non-Current Debt (2020 - 2021) Analysis & Trends

At the end of FY2020, Firefly Neuroscience posted Non-Current Debt of $356,991.

  • Five-year quarterly Non-Current Debt spans a low of $300,998 in Q2 2020 and a high of $661,533 in Q2 2021.
  • Per Business Quant data, the three quarters before Q3 2021 came in at $661,533 (Q2 2021), $300,999 (Q1 2021) and $356,991 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 39.18 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 29.60 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 25.15 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 25.62 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 14.19 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 10.92 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 13.51 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 598.70 Mn
10 Firefly Neuroscience 34.78 Mn 15.35 Mn 253,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 400,856.00
Jun 30, 2021 661,533.00
Mar 31, 2021 300,999.00
Dec 31, 2020 356,991.00
Sep 30, 2020 412,843.00
Jun 30, 2020 300,998.00
API Access

Firefly Neuroscience Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=AIFF&period=max&api_key=YOUR_API_KEY